Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor- , reduces acute inflammation

Author: Cuzzocrea S.   Pisano B.   Dugo L.   Ianaro A.   Maffia P.   Patel N.S.A.   Di Paola R.   Ialenti A.   Genovese T.   Chatterjee P.K.   Di Rosa M.   Caputi A.P.   Thiemermann C.  

Publisher: Elsevier

ISSN: 0014-2999

Source: European Journal of Pharmacology, Vol.483, Iss.1, 2004-01, pp. : 79-93

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next